|
Resolution: standard / high Figure 5.
Changes in urinary CTX-II levels after treatment of osteoarthritis patients with placebo
or risedronate. Ris, risedronate.
Spector et al. Arthritis Research & Therapy 2005 7:R625 doi:10.1186/ar1716 |
